News
The French company Orano says litigation is now its only possible recourse after Niger's Council of Ministers announced plans ...
MP0726, a Radio-DARPin candidate targeting mesothelin (MSLN) and intended for the treatment of ovarian cancer, is nominated for development under strategic partnership with Orano Med Promising tumor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results